REG1A and melanoma: REG has also been identified as a potent inhibitor of interferon-γ-induced expression of programmed death-ligand 1 and indoleamine 2,3-dioxygenase in a preclinical melanoma model, suggesting another immunomodulatory effect of REG [19].